Shares of Innoviva (NASDAQ:INVA), a biotechnology royalty company that develops respiratory therapeutics and is perhaps best known as GlaxoSmithKline’s (NYSE:GSK) development partner for its multiple next-generation COPD and asthma products, fell as much as 11% on Thursday. The reason behind Innoviva’s bad day can be traced to a proxy battle with activist hedge....More>>>
Matchpool, the incentive-based community platform that is touted as allowing anyone to open their own “matchmaking pool”, is to launch a crowdfund campaign later this month in a move described by the blockchain start-up’s CEO and co-founder Yonatan Ben Shimon, a former hedge fund manager, to disrupt the dating scene on a “global scale.”
It may be high time for stock-market bears to throw in the towel. All the pundits and prognosticators side-eyeing (that means, a sidelong glance or gaze, especially when expressing scorn, suspicion, disapproval, or veiled curiosity, according to Merriam-Webster) record-breaking equity indexes must be feeling awfully close to the point of capitulation, right about now.
Singapore's largest property developer, CapitaLand (OTCPK:CLLDY) (CATL.SI) had a pretty good 2017. Helped by improving conditions in Singapore and China, not to mention significant project openings, CapitaLand's local shares climbed 20% and the ADRs did even better.
A power outage hit the CES consumer electronics show in Las Vegas, dimming the lights in one of the main convention halls hosting demonstrations from the likes of LG Electronics Inc. and Samsung Electronics Co.
“There is an isolated power outage at the Las Vegas Convention Center. W
In Lahore and Karachi, American flags were burned in front of TV cameras after President Trump’s decision on Jan. 4 to withhold $2 billion of security aid from Pakistan to punish it for allegedly harboring terrorists. The country’s government issued angry statements claiming no ins